Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?

Background: In patients undergoing paroxysmal atrial fibrillation (PAF) ablation, pulmonary vein isolation (PVI) alone fails in maintaining sinus rhythm in up to one third of patients after a first catheter ablation. Epicardial adipose tissue (EAT), as an endocrine-active organ, could play a role in...

Full description

Bibliographic Details
Main Authors: Néfissa Hammache, Hugo Pegorer-Sfes, Karim Benali, Isabelle Magnin Poull, Arnaud Olivier, Mathieu Echivard, Nathalie Pace, Damien Minois, Nicolas Sadoul, Damien Mandry, Jean Marc Sellal, Christian de Chillou
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/14/3037
id doaj-6b975851a60349e3934533b86c930cee
record_format Article
spelling doaj-6b975851a60349e3934533b86c930cee2021-07-23T13:47:50ZengMDPI AGJournal of Clinical Medicine2077-03832021-07-01103037303710.3390/jcm10143037Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?Néfissa Hammache0Hugo Pegorer-Sfes1Karim Benali2Isabelle Magnin Poull3Arnaud Olivier4Mathieu Echivard5Nathalie Pace6Damien Minois7Nicolas Sadoul8Damien Mandry9Jean Marc Sellal10Christian de Chillou11Département de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceINSERM-IADI, U1254, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceDépartement de Cardiologie, CHRU de Nancy, F-54500 Vandœuvre-lès-Nancy, FranceBackground: In patients undergoing paroxysmal atrial fibrillation (PAF) ablation, pulmonary vein isolation (PVI) alone fails in maintaining sinus rhythm in up to one third of patients after a first catheter ablation. Epicardial adipose tissue (EAT), as an endocrine-active organ, could play a role in the recurrence of AF after catheter ablation. Objective: To evaluate the predictive value of clinical, echocardiographic, biological parameters and epicardial fat density measured by computed tomography scan (CT-scan) on AF recurrence in PAF patients who underwent a first pulmonary vein isolation procedure using radiofrequency (RF). Methods: This monocentric retrospective study included all patients undergoing first-time RF PAF ablation at the Nancy University Hospital between March 2015 and December 2018 with one-year follow-up. Results: 389 patients were included, of whom 128 (32.9%) had AF recurrence at one-year follow-up. Neither total-EAT volume (88.6 ± 37.2 cm<sup>3</sup> vs. 91.4 ± 40.5 cm<sup>3</sup>, <i>p</i> = 0.519), nor total-EAT radiodensity (−98.8 ± 4.1 HU vs. −98.8 ± 3.8 HU, <i>p</i> = 0.892) and left atrium-EAT radiodensity (−93.7 ± 4.3 HU vs. −93.4 ± 6.0 HU, <i>p</i> = 0.556) were significantly associated with AF recurrence after PAF ablation. In multivariate analysis, previous cavo-tricuspid isthmus (CTI) ablation, ablation procedure duration, BNP and triglyceride levels remained independently associated with AF recurrence after catheter ablation at 12-months follow-up. Conclusion: Contrary to persistent AF, EAT parameters are not associated with AF recurrence after paroxysmal AF ablation. Thus, the role of the metabolic atrial substrate in PAF pathophysiology appears less obvious than in persistent AF.https://www.mdpi.com/2077-0383/10/14/3037paroxysmal atrial fibrillationcatheter ablationepicardial adipose tissue
collection DOAJ
language English
format Article
sources DOAJ
author Néfissa Hammache
Hugo Pegorer-Sfes
Karim Benali
Isabelle Magnin Poull
Arnaud Olivier
Mathieu Echivard
Nathalie Pace
Damien Minois
Nicolas Sadoul
Damien Mandry
Jean Marc Sellal
Christian de Chillou
spellingShingle Néfissa Hammache
Hugo Pegorer-Sfes
Karim Benali
Isabelle Magnin Poull
Arnaud Olivier
Mathieu Echivard
Nathalie Pace
Damien Minois
Nicolas Sadoul
Damien Mandry
Jean Marc Sellal
Christian de Chillou
Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
Journal of Clinical Medicine
paroxysmal atrial fibrillation
catheter ablation
epicardial adipose tissue
author_facet Néfissa Hammache
Hugo Pegorer-Sfes
Karim Benali
Isabelle Magnin Poull
Arnaud Olivier
Mathieu Echivard
Nathalie Pace
Damien Minois
Nicolas Sadoul
Damien Mandry
Jean Marc Sellal
Christian de Chillou
author_sort Néfissa Hammache
title Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
title_short Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
title_full Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
title_fullStr Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
title_full_unstemmed Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
title_sort is there an association between epicardial adipose tissue and outcomes after paroxysmal atrial fibrillation catheter ablation?
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-07-01
description Background: In patients undergoing paroxysmal atrial fibrillation (PAF) ablation, pulmonary vein isolation (PVI) alone fails in maintaining sinus rhythm in up to one third of patients after a first catheter ablation. Epicardial adipose tissue (EAT), as an endocrine-active organ, could play a role in the recurrence of AF after catheter ablation. Objective: To evaluate the predictive value of clinical, echocardiographic, biological parameters and epicardial fat density measured by computed tomography scan (CT-scan) on AF recurrence in PAF patients who underwent a first pulmonary vein isolation procedure using radiofrequency (RF). Methods: This monocentric retrospective study included all patients undergoing first-time RF PAF ablation at the Nancy University Hospital between March 2015 and December 2018 with one-year follow-up. Results: 389 patients were included, of whom 128 (32.9%) had AF recurrence at one-year follow-up. Neither total-EAT volume (88.6 ± 37.2 cm<sup>3</sup> vs. 91.4 ± 40.5 cm<sup>3</sup>, <i>p</i> = 0.519), nor total-EAT radiodensity (−98.8 ± 4.1 HU vs. −98.8 ± 3.8 HU, <i>p</i> = 0.892) and left atrium-EAT radiodensity (−93.7 ± 4.3 HU vs. −93.4 ± 6.0 HU, <i>p</i> = 0.556) were significantly associated with AF recurrence after PAF ablation. In multivariate analysis, previous cavo-tricuspid isthmus (CTI) ablation, ablation procedure duration, BNP and triglyceride levels remained independently associated with AF recurrence after catheter ablation at 12-months follow-up. Conclusion: Contrary to persistent AF, EAT parameters are not associated with AF recurrence after paroxysmal AF ablation. Thus, the role of the metabolic atrial substrate in PAF pathophysiology appears less obvious than in persistent AF.
topic paroxysmal atrial fibrillation
catheter ablation
epicardial adipose tissue
url https://www.mdpi.com/2077-0383/10/14/3037
work_keys_str_mv AT nefissahammache isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT hugopegorersfes isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT karimbenali isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT isabellemagninpoull isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT arnaudolivier isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT mathieuechivard isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT nathaliepace isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT damienminois isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT nicolassadoul isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT damienmandry isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT jeanmarcsellal isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
AT christiandechillou isthereanassociationbetweenepicardialadiposetissueandoutcomesafterparoxysmalatrialfibrillationcatheterablation
_version_ 1721287675253620736